Your browser doesn't support javascript.
loading
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.
Krasniqi, E; Barchiesi, G; Pizzuti, L; Mazzotta, M; Venuti, A; Maugeri-Saccà, M; Sanguineti, G; Massimiani, G; Sergi, D; Carpano, S; Marchetti, P; Tomao, S; Gamucci, T; De Maria, R; Tomao, F; Natoli, C; Tinari, N; Ciliberto, G; Barba, M; Vici, P.
  • Krasniqi E; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144, Rome, Italy.
  • Barchiesi G; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144, Rome, Italy.
  • Pizzuti L; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144, Rome, Italy.
  • Mazzotta M; Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, Azienda Ospedaliera Sant'Andrea, Rome, Italy.
  • Venuti A; HPV-UNIT, UOSD Tumor Immunology and Immunotherapy, Department of Research, Advanced Diagnostic and Technological Innovation (RIDAIT), Translational Research Functional Departmental Area, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  • Maugeri-Saccà M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144, Rome, Italy.
  • Sanguineti G; Department of Radiation Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Massimiani G; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144, Rome, Italy.
  • Sergi D; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144, Rome, Italy.
  • Carpano S; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144, Rome, Italy.
  • Marchetti P; Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, Azienda Ospedaliera Sant'Andrea, Rome, Italy.
  • Tomao S; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy.
  • Gamucci T; Department of Radiological, Oncological and Anatomo-Pathological Sciences, Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy.
  • De Maria R; Medical Oncology, Sandro Pertini Hospital, Rome, Italy.
  • Tomao F; Institute of General Pathology, Catholic University of the Sacred Heart, Rome, Italy.
  • Natoli C; Department of Medical Oncology, Policlinico Universitario "A. Gemelli", Rome, Italy.
  • Tinari N; Department of Gynecology-Obstetrics and Urology, "Sapienza" University of Rome, Rome, Italy.
  • Ciliberto G; Department of Medical, Oral and Biotechnological Sciences and Center of Aging Science & Translational Medicine (CeSI-MeT), G. d'Annunzio University, Chieti, Italy.
  • Barba M; Department of Medical, Oral and Biotechnological Sciences and Center of Aging Science & Translational Medicine (CeSI-MeT), G. d'Annunzio University, Chieti, Italy.
  • Vici P; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
J Hematol Oncol ; 12(1): 111, 2019 10 29.
Article en En | MEDLINE | ID: mdl-31665051
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Predisposición Genética a la Enfermedad / Inmunoterapia Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Predisposición Genética a la Enfermedad / Inmunoterapia Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article